NEC Baby Formula Lawsuit Overview

What Is the NEC Baby Formula Lawsuit?

Thousands of families are filing lawsuits against Abbott Laboratories (maker of Similac) and Mead Johnson / Reckitt (maker of Enfamil) alleging that their cow's milk-based infant formulas caused premature babies to develop Necrotizing Enterocolitis (NEC) — a devastating and sometimes fatal intestinal disease.

NEC is one of the most serious gastrointestinal emergencies affecting premature infants. It occurs when bacteria invade the intestinal wall, causing tissue to become inflamed, die, and sometimes perforate. The mortality rate can be as high as 50% in the most severe cases.

The Science Behind the Claims

Medical research spanning decades has established that premature infants fed cow's milk-based formula face a significantly higher risk of NEC compared to those fed human breast milk or donor milk:

Multiple peer-reviewed studies show the NEC risk can be 6 to 10 times higher in formula-fed preemies
The American Academy of Pediatrics and the World Health Organization both recommend human milk as the first choice for preterm infants
Cow's milk proteins can trigger inflammatory responses in the immature digestive systems of premature babies

Despite this scientific evidence, manufacturers continued marketing their cow's milk-based formulas for use in NICUs without adequately warning parents or healthcare providers about the NEC risk.

Major Bellwether Verdicts

The litigation has produced two landmark verdicts that have reshaped the landscape:

Date	Case	Verdict	Defendant
March 2024	First bellwether	$60 million	Abbott Laboratories
July 2024	Second bellwether	$495 million	Mead Johnson (Reckitt)

These verdicts signal that juries are taking the claims seriously and sending a strong message to manufacturers.

What Are Plaintiffs Alleging?

The lawsuits allege that Abbott and Mead Johnson:

Knew or should have known about the increased NEC risk for premature infants
Failed to warn NICUs, doctors, and parents about the specific danger
Actively marketed their formulas to NICUs despite the risk
Chose profits over infant safety by continuing to sell formulas without proper warnings
Failed to recommend donor milk as a safer alternative

Current Status of the Litigation

The NEC Baby Formula litigation is consolidated as MDL 3026 in the Northern District of Illinois, before Judge Rebecca R. Pallmeyer.

Thousands of cases pending in the MDL
Bellwether verdicts of $60M and $495M have energized plaintiff recruitment
No global settlement yet — both sides continue to litigate actively
New filings are being accepted

Why You Should Act Now

If your premature baby was fed Similac or Enfamil in a NICU and developed NEC, you may have a valid claim. Time-sensitive considerations include:

Statutes of limitations vary by state
Medical records from NICUs must be preserved
Early filers are typically prioritized in settlement negotiations

A free case review costs nothing. If your family has been affected by NEC, an experienced attorney can evaluate whether you have grounds for a lawsuit.